CD4 and neoplasm: The results of previous studies utilizing genetically engineered mouse models [11] and our examination of human PDAC specimens suggested that a decrease in tumor-stromal collagen in PDAC negatively affected the anti-immune system, such as CD4+ and CD8+ TILs.